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Abstract 
During inflammation, the resulting oxidative stress can damage surrounding host tissue, forming 
protein-carbonyls.  The SJL mouse is an experimental animal model used to assess in vivo 
toxicological responses to reactive oxygen and nitrogen species from inflammation.  The goals of 
this study were to identify the major serum proteins modified with a carbonyl functionality and 
to identify the types of carbonyl adducts.  To select for carbonyl-modified proteins, serum 
proteins were reacted with an aldehyde reactive probe (ARP) that biotinylated the carbonyl 
modification.   Modified proteins were enriched by avidin affinity and identified by 2-D LC-
MS/MS.  To identify the carbonyl modification, tryptic peptides from serum proteins were 
subjected to avidin affinity and the enriched modified peptides were analyzed by LC-MS/MS.  It 
was noted that the ARP tag created tag-specific fragment ions and neutral losses, and these extra 
features in the mass spectra inhibited identification of the modified peptides by database 
searching.  To enhance the identification of carbonyl-modified peptides, a program was written 
which used the tag-specific fragment ions as a fingerprint (in silico filter program) and filtered 
the mass spectrometry data to highlight only modified peptides.  A de novo-like database search 
algorithm was written (biotin peptide identification program, BPI) to identify the carbonyl-
modified peptides.  Although written specifically for our experiments, this software can be 
adapted to other modification/enrichment systems.  Using these routines, a number of lipid 
peroxidation-derived protein carbonyls and direct side-chain oxidation proteins carbonyls were 
identified in SJL mouse serum.   
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Introduction 
During inflammation, activated phagocytes secrete reactive nitrogen species (RNS) and 
reactive oxygen species (ROS) that can eliminate infectious agents.  If inflammation is chronic, 
RNS and ROS can also damage surrounding host tissue, resulting in protein modification in the 
form of protein-carbonyls (1).  Total protein carbonylation has been used as a marker of 
oxidative stress and inflammation (2) and increased levels have been seen in heart disease, lung 
disease, aging, neurodegenerative disorders, and inflammatory bowel disease (2-7).  The 
carbonylation of proteins can result from the direct oxidation of protein side-chains, forming the 
glutamate and aminoadipate semialdehydes (Scheme 1) (8,9), but can also occur from the 
indirect oxidation of polyunsaturated fatty acids (lipid peroxidation) and carbohydrates, leading 
to a variety of reactive aldehydes (Scheme 2) (10).  These aldehydes covalently modify proteins 
through conjugate addition (often Michael addition) to nucleophilic amino acid side chains, 
creating protein-bound carbonyls (10,11).   
 In a previous study, twelve DNA oxidative damage products, from tissues from the SJL 
mouse model of inflammation, were quantitated (12).  Only the lipid peroxidation adducts 
increased in association with inflammation, which suggested an important role of lipids in 
inflammatory disease progression and established a direct correlation between inflammation and 
the increased formation of reactive aldehydes from oxidized lipids.  Although DNA modification 
due to inflammation has been the focus of many animal and human studies, it is proteins that are 
considered most likely to be ubiquitously affected by disease, response and recovery (13), and 
the biological consequences include more-rapid protein turnover as well as novel signaling (14-
16) .  The overall carbonylation of proteins has been well documented in other inflammatory 
animal models, which have shown significant increases in protein-carbonyls in the mucosal 
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lining of rat colon (17) and mouse colon(5) while increased levels of protein carbonyls were 
observed in rat serum, along with a higher turnover of proteins from the inflamed tissue (18,19).  
Furthermore, increased protein carbonyl modification has been reported in studies of the colon 
mucosal lining from patients diagnosed with inflammatory bowel disease (20,21).  Taken 
together, these observations suggest that an increase in carbonylated proteins is likely in the SJL 
mouse and that the extent and type of protein-carbonyls could potentially be a marker for 
inflammation and disease.   
The SJL mouse is an experimental animal model used to assess in vivo toxicological 
responses to nitric oxide (NO) overproduction from inflammation (22).  Injections of RscX 
lymphoma cells into these mice result in rapid tumor growth as well as host T cell proliferation 
in lymph nodes, spleen and liver, resulting in morbidity within 15 days.  The induced 
macrophages create a 50-fold increase in NO production in spleen and lymph nodes and the post 
translational modification 3-nitrotyrosine was highly elevated in spleen tissue. 
The identification of endogenously formed protein carbonyls in serum is challenging due 
to their low abundance and the large number of possible modifications (1,2,23), some of which 
are shown in schemes 1 and 2.  We recently identified proteins modified by the carbonyl 9,12-
dioxo-10(E)-dodecenoic acid (DODE) in cells treated with the hydroperoxide of linoleic acid 
(13-HPODE) (24).  This work used a technique first demonstrated by Maier and co-workers 
(25,26).  Protein carbonyls were derivatized with an aldehyde reactive probe (ARP), a 
biotinylated hydroxylamine that reacts preferentially with aldehyde/keto groups (27), allowing 
for subsequent enrichment of the modified proteins by avidin affinity.  DODE-modified proteins 
were also identified using an anti-DODE antibody and Western blots.  Although a number of 
DODE modified proteins were identified, we were unable to definitively identify the carbonyl 
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modified peptides by mass spectrometry due both to low abundance and to the interference of 
ARP-tag-specific fragment ions on database searching.   
In this current study, SJL mouse serum was screened for the presence of protein 
carbonyls endogenously formed during inflammation.   Carbonyl-modified proteins were then 
identified using techniques previously established (24); first anti-DODE Western blotting 
followed by ARP derivatization/enrichment and 2D-LC-MS/MS.  These proteins then formed a 
database of putative carbonyl-modified proteins from SJL mouse serum.  To identify the type of 
carbonyl modification and the modified peptide, the ARP derivatized peptides were enriched and 
analyzed by mass spectrometry.  To minimize the confounding effect of ARP fragmentation, an 
algorithm (in silico filter) was written that filtered the mass spectrometry data to select only 
those peptides containing the known ARP pattern of fragmentation.  This alone effectively 
reduced the number of false positives.  To further alleviate the interfering effects of ARP 
fragments on peptide identification by database searching, a de novo searching algorithm (Biotin 
Peptide Identification program, BPI) was written.  Peptides were evaluated against the database 
of proteins that had been previously identified as potentially carbonyl modified.  Since modified 
peptides were searched against a finite list of proteins and all results were manually evaluated, 
the BPI program did not calculate a statistical peptide score, which allowed the identification of 
lower abundant modified peptides that would not be considered significant by standard search 
engines such as Mascot.  The BPI program was also written with the flexibility to evaluate a 
wide range of known carbonyl-adduct masses and could therefore screen for a large number of 
carbonyl adducts at one time.  This should also allow the program to be used with 
modification/enrichment systems other than the one used here.  The program thus selected a 
finite number of carbonyl modified peptides, resulting in the identification of a number of 
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proteins that were endogenously carbonylated in serum from the SJL mouse inflammation 
model. 
 
Materials and Methods 
 Materials.  Aldehyde reactive probe (ARP) was purchased from Invitrogen (Eugene, 
OR) and biotin-PEO-LC-Amine was purchased from Pierce (Rockford, IL).  Cytochrome c 
(equine heart), acetic acid, and trifluoroacetic acid were purchased from Sigma Chemical Co. 
(St. Louis, MO).  Trypsin was purchased from Promega (Madison, WI).  Gases were supplied by 
AirGas (Salem, NH).  DODE was a generous gift from Prof. Ian A. Blair (University of 
Pennsylvania). 
SJL mouse infection and serum extraction.  RcsX cells (kindly supplied by Prof. 
Nicolas M. Ponzio, University of New Jersey Medical Center, Newark, NJ) were passaged 
through SJL mice (Jackson Laboratory, Bar Harbor, ME) and harvested from lymph nodes 14 
days after inoculation according to published procedures (28). Cells were manually dissociated 
from lymph nodes followed by washing in phosphate-buffered saline (PBS; 140 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and freezing in aliquots of 5 x 107 cells in 
10% dimethylsulfoxide/fetal bovine serum. To initiate NO overproduction, eight SJL mice (5–6 
weeks old) were each injected intra-peritoneally with 107 RcsX cells in 200 µL of PBS.  Ten 
mice were injected with 200 µL of PBS as unstimulated controls. Twelve days after injection, 
five treated and three control mice were anaesthetized with isofluorane, and serum was collected 
by cardiac puncture.  Pooled samples were desalted by filter centrifugation and dried in a 
SpeedVac.  Protein content  was determined with a commercial bicinchoninic acid (BCA) 
protein assay kit (Pierce).  
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SDS-PAGE of SJL mouse serum, 1 and 2-D.  100 µg (Coomassie) or 30 µg (Western) 
of sample was processed by 2-D gel electrophoresis for protein identification/Western blotting.  
For anti-biotin Western blotting and Coomassie, proteins were focused on 11 cm 4-7 
immobilized pH gradient (IPG) strips (Immobiline™ DryStrip gels, Amersham Biosciences) 
using an IPGphor focusing apparatus (Amersham Biosciences).  For anti-DODE western blotting 
and Coomassie staining, proteins were focused on an 11 cm 3-10 pH gradient strip.  Samples 
were applied by cup loading.  IPG strips were then equilibrated in equilibration buffer (50 mM 
Tris-HCl, 6M urea, 30% glycerol, 2% SDS) supplemented with 1% dithiothreitol (DTT) to 
maintain the fully-reduced state of proteins, followed by 2.5% iodoacetamide to prevent re-
oxidation of thiol groups during electrophoresis. Proteins were separated on 12.5% Tris/Glycine 
gels (BioRad) using a Criterion System (BioRad).  Proteins were visualized by Coomassie   
SimplyBlue SafeStain™ (Invitrogen).  
Anti-Biotin and Anti-DODE Western blots.  Proteins were transferred to a 
polyvinylidine fluoride (PVDF) membrane (BioRad). Precision Plus protein standard (BioRad) 
was used to estimate molecular weights.  Anti-biotin (Cell Signaling) 1:20,000 was used to 
detect biotinylated proteins.  Polyclonal anti-DODE antibody (29) 1:1500 was used to detect 
DODE-modified proteins. 
In-Gel Digestion.  Protein spots were picked and washed in Milli-Q water for 15 min, 
then washed three times in 25 mM NH4HCO3/50% CH3CN for 30 minutes. Gel plugs were 
dehydrated in 100% CH3CN for 10 min while vortex-mixing. The supernatant was removed, and 
the plugs were dried in the SpeedVac.  Trypsin (1µg/50µL) (Promega) suspended in 25 mM 
NH4HCO3 was added, and gel plugs were re-hydrated for 30 min on ice and then digested 
overnight at 37˚C. The samples were then centrifuged, and the supernatant was removed. The 
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pellet was re-suspended in CH3CN with 1% TFA, vortexed, and sonicated for 30 minutes to 
release hydrophobic peptides.  The supernatant was removed and combined with the previous 
supernatant and stored at -20˚C until ready for MS/MS analysis. 
Neutravidin affinity chromatography of ARP derivatized serum proteins.  
Neutravidin was used to enrich for ARP-carbonyl derivatized proteins from SJL serum.  
These proteins were identified (described below) to make up the protein database used in the 
Biotin Peptide Identification program.   Immobilized neutravidin (Pierce) was packed into a 
column with dimensions ID = 9 mm, OD = 7 mm, height = 60 mm.  The final column volume 
was 2 mL.  All buffers and samples were brought to room temperature.  The column was washed 
with 4 column volumes of PBS.  A protease inhibitor cocktail was added to the protein samples: 
AEBSF (1 mM), E-64 (10 µM), pepstatin A (1.4 µM), EDTA (1 mM), bestatin (40 µM).  
Samples (~ 2 mg protein in 1 mL PBS) were added directly to the neutravidin column.  To 
remove non-biotinylated proteins, the column was washed with 10 column volumes of PBS-2% 
3-[(3-cholamidopropyl)dimethylammonio]propanesulfonic acid (CHAPS), 5 column volumes of 
PBS and 5 column volumes of deionized water.  Wash fractions were analyzed by UV-Vis 
spectrometry for baseline absorbance (280 nm).  Bound proteins were eluted by the addition of 4 
column volumes of 0.4% TFA/80% acetonitrile.  Elution fractions were combined, frozen, 
lyophilized, and stored at -20°C. 
Neutravidin affinity chromatography of ARP derivatized serum peptides.  
Neutravidin columns were prepared as described above.  Serum proteins were digested in-
solution to peptides with trypsin as follows: to 200 µg of protein 4 µg of sequencing grade 
trypsin (Promega) was added in ~200 µL 50 mM ammonium bicarbonate; proteins were digested 
for 4 hours at 37°C.  Total serum peptide digests were added directly to the neutravidin column.  
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Non-biotinylated peptides were removed with 10 column volumes of PBS-2% 3-[(3-
cholamidopropyl)dimethylammonio]propanesulfonic acid (CHAPS), 5 column volumes of PBS 
and 5 column volumes of deionized water.  Bound peptides were eluted by the addition of 4 
column volumes of 0.4% TFA/80% acetonitrile.  Elution fractions were combined, frozen, 
lyophilized, and stored at -20°C. 
DODE modification and ARP derivatization of mouse serum albumin and 
cytochrome c.  Mouse serum albumin and cytochrome c (1 mg/mL, 100 µl in pH 7.0 chelex-
treated 100 mM HEPES buffer) were reacted with DODE (224 nmols, 10 µL ethanol) in the 
presence of vitamin C (10 mM) at 37°C for 24 h.  Proteins were filtered (regenerated cellulose 
3,000 Da MWCO; Amicon,) to remove un-reacted DODE and vitamin C, and brought up in PBS 
to a concentration of 1 mg/mL.  DODE modified protein samples (1 mg/mL) were incubated 
with Aldehyde Reactive Probe (ARP) (10 mM) at a final volume of 1.0 mL in phosphate buffer, 
pH = 5-6.  The reaction was stirred vigorously for 12 hours at room temperature. The samples 
were filtered (regenerated cellulose 3,000 Da MWCO; Amicon,) to remove unreacted ARP. 
Strong cation exchange (SCX) separation for SJL serum proteins.   
Neutravidin elutions of proteins from SJL mouse serum were digested in-solution with trypsin as 
follows: to 200 µg of protein 4 µg of sequencing grade trypsin (Promega) was added in ~200 µL 
25 mM ammonium bicarbonate; proteins were digested for 4 hours at 37°C.  Digested proteins 
were desalted by SPE (Strata 50um, tri-Func, C18-E), dried and re-dissolved in 100 µL mobile 
phase A (described below) for SCX separation.  Purified peptides were separated by SCX liquid 
chromatography using an Agilent 1100 LC system with a Polysulfoethyl A 100 x 4.6 mm, 5 µm 
column (Nest Group) and a flow rate of 0.25 mL/min.  Mobile phase A was 10 mM sodium 
phosphate (Na2HPO4),  25% acetonitrile, pH = 2.8 and mobile phase B was 10 mM sodium 
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phosphate (Na2HPO4), 25% acetonitrile, 0.4 M KCl, pH = 2.8.  A linear gradient was as follows:  
0% B from 0-10 min, 100 % B at 70 min, 100% B at 75 min and 0% B at 80 min.  Peptides were 
collected in 1-minute fractions to give about 40-60 fractions per sample.  These were each 
desalted by ZipTips and re-dissolved in 5 µL 0.4% acetic acid for LC-ESI-MS/MS analysis.  
LC-MS/MS (Applied Biosystems QStar Elite).  The electrospray interface for this 
instrument uses a micro-tee (Upchurch Scientific, Oak Harbor, WA) with a 1-in. piece of 
platinum rod, inserted into one arm of the micro-tee, to supply the electrical connection. The 
electrospray voltage was typically 1600-1700 V applied just upstream of the column. Data-
dependent MS/MS analysis was performed on the three most intense peaks in each full-scan 
spectrum, using multiply-charged states (most of the non-peptide background constituents are 
singly charged).  Samples were spiked with 100 fmoles of vasoactive intestinal peptide fragment 
(amino acids 1-12) as the internal standard for calibration and mass accuracy.   
Accumulation time and pulsar frequency were maintained at 3 seconds and 6.99 seconds, 
respectively; the mass tolerance was 50 mmu.  MS/MS was performed using nitrogen as the 
collision gas.  Rolling collision energies were calculated as follows: z = 1, (collision energy) = 
0.06*(m/z) + 8; z = 2, (collision energy) = 0.05*(m/z) + 5.6; z = 3, (collision energy) = 
0.04*(m/z) + 6.7; z > 3, (collision energy) = 0.015*(m/z) + 25.  Chromatography was performed 
using an Agilent 1100 capillary LC system with fused-silica capillary columns (75 µm i.d. × 360 
µm o.d.; 14 cm length, tip 8 µm, New Objective, Woburn, MA) that were packed in-house with 
5-µm C18 reverse-phase material (Vydac, Hesperia, CA).  The flow rate from the pumps was 3-5 
µL/min, and flow was split, before introduction of the sample onto the column, to 100-200 
nL/min.  Solvent A was 0.5% acetic acid in water and solvent B was 0.5% acetic acid in 
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acetonitrile.  A linear gradient was performed as follows: 2% B at 0 min, 2% B at 3 min, 65% B 
at 70 min, 80% B at 80 min, 80%B at 90 min, 2%B at 130 min, and 2% B at 170 min.   
Protein and peptide and modification identification and characterization.  Peak lists 
for the Applied Biosystems QSTAR Elite were generated as mgf files by Applied Biosystems 
Analyst QS 1.1 software. 
  Database searches were carried out using Mascot version 2.2 (Matrix Science).  For 
protein identification, either the NCBInr and/or the SwissProt mouse databases were searched.  
Parameters included: enzyme: trypsin; max missed cleavages = 2; fixed modifications 
carbamidomethyl (C) for 2-D gel analysis only; variable modifications of methionine oxidation 
(M); precursor tolerance was set at 0.1 Da; MS/MS fragment tolerance was set at 0.2 Da.  
Proteins were identified with 3 or more peptides.  Significance of a protein match for Mascot 
was based on an expectation value of < 0.05 and a combined peptide score > 50.   
For ARP-carbonyl modified peptides, the Mascot modification file was edited to add the 
DODE-ARP modification with elemental composition C24H37N5O7S (calculated monoisotopic 
mass 539.2414 Da) and specificity for lysine.  In addition to the elemental composition of the 
modifying group, the Mascot modification file allows for the inclusion of neutral losses, used in 
scoring of a fragment ion spectrum and for the peptide neutral loss.  The Mascot modification 
file also allows for ions to be ignored in scoring (“Ignore Masses”).  Neutral losses and ignored 
ions were determined experimentally for ARP-DODE.  Neutral-loss fragments included the 
entire modifying group, C24H37N5O7S (calculated monoisotopic mass 539.2414 Da) and the ARP 
portion of the modifying group, C12H21N5O4S (calculated monoisotopic mass 331.12124 Da).  
“Ignore Mass” ions included C10H15N2O2S (calculated monoisotopic mass 227.0854 Da), 
C10H19N4O2S (calculated monoisotopic mass 259.1229 Da), C12H19N4O3S (calculated 
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monoisotopic mass 299.1178 Da)  and C12H22N5O4S (calculated monoisotopic mass 332.1393 
Da). 
Programming language.  All programming for the in silico filter program and the Biotin 
Identification Program was done in Python Programming Language (http://www.python.org).   
Python programs were written to be used on the Macintosh OS X operating system.  Python text 
files for the in silico filter program and the Biotin Identification Program are available for view 
or download at:  http://web.mit.edu/toxms/www/filters.htm. 
 
Results 
Identification of putative carbonyl modified proteins.  Proteins modified by carbonyls 
were identified by methods previously established (24).  SJL mice were injected with RcsX 
lymphoma cells as described in Materials and Methods while control mice were injected with 
PBS.  After 12 days, mice were bled and serum separated by centrifugation to generate infected 
and control SJL mouse serum samples.  Samples were aliquoted and stored at -80°C.  
Twenty µg of ARP-derivatized and non-derivatized serum proteins from control and 
infected SJL mice were separated by 1-D SDS-PAGE and analyzed by Western blot using either 
Streptavidin-HRP or an anti-DODE to analyze ARP-derivatized and non-derivatized respectively 
(Figure 1).   No DODE-modified proteins were detected in control mice, establishing the 
background level of DODE-modified proteins at essentially zero.  Streptavidin-HRP Western 
blot analysis of carbonyl-modified proteins (ARP derivatized) from control (uninfected) SJL 
mouse serum demonstrated a low abundant background of carbonylation.  This low amount of 
modified protein was below the detection limit of our mass spectrometry methods and therefore 
background carbonylation was also considered to be zero.  Although abundant serum proteins are 
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generally considered poor markers of disease and inflammation, carbonyl-modification of these 
proteins may be of interest, therefore the most abundant serum proteins such as albumin or 
transferrin were not depleted prior to analysis.  This decision likely limited the identification of 
lower abundant carbonyl-modified proteins but allowed the identification of potentially 
important carbonyl modifications on some of these abundant proteins.   
Identification of DODE-modified proteins.  To identify DODE-modified protein 
candidates, proteins from the infected mouse serum were separated by 2-D SDS-PAGE and the 
modified proteins located by anti-DODE Western blot (Supplementary Material Figure 1).  
Protein spots were cut from a corresponding Coomassie-blue-stained 2-D gel and digested with 
trypsin.  Proteins were identified by nano-LC-MS/MS and Mascot data base searching.  A 
relatively small number of potential DODE carbonyl-modified proteins were identified by this 
method (these are highlighted in red in Supplemental Table ST1).   
Identification of carbonyl-modified proteins.  To identify serum proteins modified 
with carbonyls other than DODE, serum from the infected SJL mouse was reacted with the 
aldehyde reactive probe (ARP) and modified proteins were enriched by avidin affinity as 
described in Materials and Methods.  Enriched modified proteins were digested with trypsin and 
peptides, then separated by 2D chromatography (strong cation exchange (SCX) and reverse 
phase).  Proteins were identified by tandem mass spectrometry and Mascot database searching.  
shows the complete list of putative carbonyl-modified proteins identified by both the 2D gel anti-
DODE method and the ARP 2D chromatography method.  Proteins identified by both methods 
are highlighted in red and were considered likely candidates for DODE modified serum proteins.  
This list of proteins was used as a database for the identification of the carbonyl modified 
peptides, as described below. 
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Database searching of ARP-DODE modified peptides.  The ARP tag can generate tag-
specific fragments and neutral losses that inhibit successful database searching (24).  To further 
explore this issue a DODE-ARP modified cytochrome c standard was prepared as previously 
described (24,30).  Modified cyt c was enriched by avidin affinity, digested with chymotrypsin 
and analyzed by nano-LC-MS/MS (Materials and Methods).  As previously reported (30), 
DODE was found to modify lysines on three chymotryptic peptides; 98LKKATNE104, 
83AGIKKKTEREDLIAY94 and acyl-1GDVEKGKKIF10.  To evaluate the effectiveness of 
database searching to identify ARP derivatized carbonyl-modified peptides, mass spectrometry 
data was searched using Mascot with the DODE-ARP modification (C24H37N5O7S) added to the 
Mascot modification file. 
The derivatization of protein carbonyls by ARP in effect doubles the size of the 
modification, increasing the tendency of the modification to undergo fragmentation by collision 
induced dissociation (CID).  Figure 2 shows typical fragmentation patterns of the peptide acyl-
1GDVEKGKKIF10, both unmodified (2A) and ARP-DODE modified (2B).  In Figure 2B the 
ARP-tag-specific fragment ions, as well as peptide fragment ions with a neutral loss from the 
modification, are annotated.  Figure 2C shows the ARP fragments (m/z  227, m/z  332, m/z 299 
and m/z 159).    
Initially it was observed that the ARP-specific fragments (m/z  227, m/z  332, m/z 299 and 
m/z 159) decreased the Mascot statistical score to the extent that even visually-good product ion 
spectra produced no positive hits.  Following adjustment of the Mascot modification file to 
ignore these fragments, the peptides were identified correctly.  Mascot scores of modified 
peptides, however, remained statistically low (M-score = 15-20), and it was therefore assumed 
that the ARP-specific fragments were not completely ignored, but were reduced in significance 
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while still taken into account during scoring.  This type of interference has also been observed 
with the biotin-containing ICAT tag (31). 
Another consequence of ARP fragmentation was the introduction of diagnostic neutral 
losses into the MS/MS spectra.  To improve the peptide identification statistical score, the 
previously-noted neutral losses of 331 Da and 539 Da were added to the Mascot modification 
file.  Neutral losses for y/b fragment ions and peptide neutral losses were also accounted for.  
Scores then increased to 25, 30 and 22 for the peptides 1GDVEKGK*KIFI10, 98LK*KATNE104 
and 83AGIK*KKTEREDLIAY94 respectively.  Unmodified peptides nonetheless consistently 
showed significantly higher scores (> 50); this discrepancy of scores between modified and 
unmodified peptides is explained as follows.  The Mascot peptide score (Mowse score or M-
score) is calculated on a probability that the observed match between the experimental data set 
and sequence database entry is a chance event or M-score = -10*log(P) where P is the 
probability, i.e., the lower the probability the higher the score.  The probability, P, is directly 
dependent on the number of theoretical fragment ions per given peptide, i.e., the greater the 
number of fragments the higher the probability of a mismatch.  The addition of neutral losses as 
well as modifications greatly increases the number of possible fragments.  For example, Mascot 
calculated that the unmodified peptide GDVEKGKKIF would have 91 theoretical fragments; 24 
ions were identified out of the 91 and the peptide received an M-score of 51.  The equivalent 
DODE-ARP-modified peptide GDVEKGK*KIF had a calculated 181 theoretical fragments due 
to neutral loses and the variable modification; 39 ions of the 181 were identified and the peptide 
received an M-score of 19.  Assuming that both peptides (modified and unmodified) were treated 
identically, had similar mass spectra, similar number of background ions, similar fragmentation 
efficiency and similar peak list extractions, then scoring of the biotin modified peptides was 
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directly limited by Mascot’s probability, P, calculation.  Achieving the highest score for biotin-
modified peptides therefore becomes a balancing act.  The addition of neutral losses to the search 
parameters must not overly increase the theoretical number of fragment ions (and thus increase 
P) but be sufficient to correctly identify peptide fragments (resulting in lowered P).  For the 
example above, since the peptide neutral loss accounted for only one ion in the MS/MS 
spectrum, it was removed from the modification file.  Although this ion was no longer scored, 
the theoretical number of possible fragments decreased to 178, which slightly increased the 
peptide M-score to 20. 
The effect of modification on peptide M-Score.  To better understand the effect of the 
ARP-DODE modification on peptide identification, the doubly-charged unmodified and 
modified peptides (acyl-1GDVEKGKKIF10) were subjected to various collision energies, and 
Mascot peptide M-scores and fragmentation efficiencies were calculated.  Fragmentation 
efficiency was defined as the ratio of the summed abundances of identified product ions divided 
by the total ion abundance.  Since only the efficiency of peptide fragmentation was being 
measured, biotin/ARP specific fragment ions (227, 259, 299 and 332) and neutral losses (331 
and 539) were excluded from these calculations.  The results indicated that the collision energies 
required to elicit a correct Mascot score (Figure 3A) and for effective fragmentation (Figure 3B) 
were almost twice as large for ARP-DODE modified peptides than for the corresponding 
unmodified peptides.  In fact, energies sufficient to fragment unmodified peptides produced little 
fragmentation in modified peptides, which remained unidentified (score = 0).  An overall 
decrease in fragmentation efficiency of the modified peptide was observed.  As previously seen, 
Mascot scores of modified peptides remained low compared to unmodified peptides.  Scores for 
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modified peptides also declined at higher collision energies due to the increasing dominance of 
biotin/ARP label-specific fragments in the MS/MS spectra. 
Identification of ARP-DODE modified peptides in SJL mouse serum by Mascot.  
Serum from RcsX-infected SJL mice serum was reacted with ARP, digested with trypsin and the 
modified peptides enriched by avidin affinity (Materials and Methods).  Enriched peptides were 
analyzed by nano-LC-MS/MS and modified peptides were identified using Mascot (Materials 
and Methods).  The ARP-derivatized lipid peroxidation adducts 4-hydroxy-2(E)-nonenal (HNE-
ARP), 4-oxo-2(E)-nonenal (ONE-ARP) and 9,12-dioxo-10(E)-dodecenoic acid (DODE-ARP) 
were added to the Mascot modification file and searching parameters were adjusted to account 
for ARP fragments and neutral losses as previously described.  The DODE modified peptide 
549K*QTALAELVK558 was identified in mouse serum albumin (Figure 4A).  The DODE 
modification was seen on lysine 549, causing a missed cleavage during tryptic digestion.  The 
peptide was identified with a peptide M-score of 34, statistically low but similar to what has 
previously been seen with the DODE-ARP cyt c peptides.  Peptide fragmentation resulted in 
complete series of y ions and a partial series of b ions, along with the neutral loss of the entire 
DODE-ARP modification from the peptide (m/z = 1100) and the neutral loss of ARP from b2 
(m/z = 465).  To further confirm this peptide modification, mouse serum albumin was reacted in 
vitro with DODE; reacted protein was derivatized with ARP, digested with trypsin and modified 
peptides enriched by avidin affinity (Materials and Methods).  The DODE-ARP modified tryptic 
peptide K*QTALAELVK was also identified, showing an identical mass spectrum fragmentation 
pattern, (Figure 4B).  The expected ARP fragment ions (227, 259 and 299) were identified in 
both the endogenously modified peptide and the in vitro DODE-ARP modified peptide, verifying 
ARP derivatization of these peptides. 
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Analysis of the raw mass spectrometry data clearly showed an abundance of ARP 
derivatized peptides as seen by the identification of the ARP tag specific fragment ions, but 
further database searching by Mascot did not reveal other peptides that could be verified as 
modified by the carbonyls HNE, ONE and DODE.  As previously described, the ARP fragments 
and neutral losses were artificially decreasing the peptide M-scores, introducing a significant 
increase in the number of false positives, thus requiring manual verification of possible hits.   
Real database hits were easily lost in the hundreds of low scoring spectra that were incorrectly 
identified as carbonyl-modified.  Manual searching of all spectra proved unrealistic, and it was 
also probable that lower-abundant modified peptides would potentially remain un-scored and 
therefore unidentified due to the interfering effects of the ARP fragments and neutral losses 
(previously demonstrated with the DODE-ARP cyt c standards).  Therefore a new method for the 
identification of these ARP derivatized peptides was explored. 
In silico filter program for the identification of ARP derivatized peptides.  As 
previously noted, ARP-specific fragments and neutral losses (Figure 2C) can inhibit successful 
database searching and increase the number of false positives.  These same values, however, 
constitute a potential fingerprint to locate the ARP-carbonyl modified peptides within the 
MS/MS raw data.  Manual extraction of these ions from MS/MS raw data is possible but time- 
consuming and impractical, therefore a program was written (Materials and Methods) to search 
for these signals in the MS/MS peak lists generated from data-dependent tandem mass 
spectrometry experiments: the in silico filter program.  A general outline of the program is 
shown in Figure 5.  The raw data is first converted to peak lists using the Mascot script 
associated with the Analyst software.  This built-in script converts the raw mass spectrometry 
data into text files (mgf files or Mascot Generic Files) containing the parent ions identified by the 
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mass spectrometer along with their associated CID fragment ions and intensities (see 
http://www.matrixscience.com/help/data_file_help.html).  The in silico filter program scans the 
peak lists within an mgf file to identify lists that contain the ARP fragment ions (227.0854, 
332.1387, 299.1127 and 259.1223).  The program also searches for parent ions with a neutral 
loss of 331.1344; corresponding to the ARP (Figure 2).  It then creates a set of five new filtered 
mgf files.  The first of these (filter file #1) is made up of peak lists containing the ion at m/z  227, 
corresponding to the most-frequent biotin fragment.   The second (filter file #2) contains peak 
lists with m/z 227 plus one other fragment ion (m/z 332 or 299 or 259).  Peak lists in the third file 
(filter file #3) contain m/z 227 plus two or more fragment ions.  The fourth file (filter file #4) 
required peak lists to contain all four fragment ions.  Finally, the fifth filtered file (filter file #5) 
requires the peak lists to contain all four fragment ions and the parent ion with the neutral loss of 
331.  These five filtered mgf files allow the user to choose the extent of filtration with the first 
file corresponding to the least filtered and the fifth file to the most filtered.  In general, the 
presence of three or more fragment ions (filter file #3) was sufficient to mark a peptide as 
modified with a high degree of confidence.    
Fragmentation of the peptide backbone occasionally resulted in the formation of some 
ARP biotin tag fragment ions (227.0854, 332.1387, 299.1127 and 259.1223).  To increase the 
specificity for these ions, the user could enter an accurate-mass value between ± 1.0 Da and 
0.0001 Da.  Values in the range of ± 0.01 - 0.001 Da would generally exclude any ions that were 
associated with peptide fragmentation rather than ARP fragmentation.  For these experiments, all 
tandem mass spectrometry runs contained an internal standard allowing for a mass accuracy 
within 5 ppm (about ± 0.001 Da).   
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To prevent the program from selecting apparent ARP fragment ions from the noise of the 
MS/MS spectra, the program calculates the maximum peak intensity for the ions in each 
individual peak list.  The user then enters the desired percent of this maximum peak intensity to 
determine a threshold above which ARP-fragments are considered to be present.  By inspection, 
we noted that for ARP derivatized peptides this maximum ion was usually the m/z 227 biotin 
fragment.  In general a threshold of 10% of the maximum peak intensity will exclude ions 
associated with the noise, but allow the program to identify some of the lower-abundance 
authentic ARP fragments.  
The ability of the filter program to highlight only ARP derivatized peptides was tested 
with an ARP-DODE cytochrome c standard that was digested with chymotrypsin and analyzed 
by LC-MS/MS.  The raw mass spectrometry data was extracted into an mgf peak list file and 
filtered using the in silico filter program with mass accuracy set to ± 0.01 Da and a threshold of 
10% of maximum peak intensity for fragment ions.   The mgf output files as well as the 
unfiltered mgf file were then analyzed with Mascot.  Table 1A shows the Mascot results from the 
unfiltered mgf file and the filter file #3 (requiring three or more ARP fragment ions).  The 
unfiltered file resulted in the identification of cyt c and its DODE-ARP modified peptides as well 
as many unmodified peptides of cyt c, chymotrypsin and keratin.  The unfiltered file also 
included one false-positive modified peptide in chymotrypsin.  The search of the filtered data 
identified only the modified peptides (Table 1B), with the notable removal of the chymotrypsin 
false positive.  None of the DODE-ARP cyt c peptides were lost due to the filtering process.  
Searching with filter file #5 (requiring all five ARP associated ions) reduced the results to three 
modified peptides, while searching with filter file #1 (requiring the single ARP fragment at m/z 
227 ) only slightly increased the number of unmodified peptides.  It was concluded that a 
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minimum of three ARP fragment ions with abundances above 10% of the maximum ion was 
sufficient to filter modified peptides.  A corresponding study using DODE-ARP modified BSA is 
included in the Supplementary Material; Figure 2. 
In summary, the in silico filter program highlighted only carbonyl-ARP modified 
peptides and significantly reduced the complexity of the mgf file submitted for database 
searching.  Three ARP fragment ions were sufficient to filter modified peptides from unmodified 
peptides and an intensity for ARP fragment ions of 10% of the maximum ion intensity as well as 
a mass accuracy window of ±0.001 Da gave a high degree of confidence that filtered peptides 
were modified.  Submitting a filtered mgf file for database searching reduced the occurrence of 
false positive hits since only modified peptides were searched.  The in silico filter program code 
is available to view or to download at: http://web.mit.edu/toxms/www/filters.htm. 
Biotin Peptide Identification Program.  The in silico filter program output files for the 
DODE-ARP cyt c standard (described above) highlighted a significant number of modified 
peptides (or peak lists) that remained unidentified by Mascot, therefore a de novo-like 
sequencing database search algorithm was written: the biotin peptide identification program 
(BPI).  The BPI program was written to search the mgf files generated from the in silico filter 
program, and identify the modified peptides, without prior knowledge of the molecular weight of  
the carbonyl modification.  This enabled searching at one time the many possible variations of 
protein carbonyls.   
To run the BPI program, the user first enters a desired modification mass range (from 
±0.0001 Da to large as necessary).  The program then selects a peak list from the filtered mgf 
file.  To improve identification specificity, the fragment ion masses in the peak list are calibrated 
using the known masses of the ARP fragment ions (single or multi point calibration as specified 
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by user).  The program then calculates a background intensity level of the peak list being 
searched to prevent consideration of ions in the noise of the spectrum (further information on 
background calculation can be seen at http://web.mit.edu/toxms/www/filters.htm).  The BPI 
program virtually digests (tryptic or chymotryptic) the protein database being searched.  The 
parent ion from the peak list being searched is compared to each peptide mass of the virtually 
digested peptides from the database.  If the differences in mass are within the specified 
modification mass range, this difference is saved as a potential carbonyl modification mass for 
that peptide.   The peptide is identified by comparing the y and b ions of the virtual peptide with 
the experimental peak list fragmentation ions as described below.   
For a match to be significant, the program first calculates the percent coverage of 
unmodified y and b fragment ions identified in the experimental peak list.  If this is lower than 
25-50% (user specified) the peptide is rejected.  (Since the peak lists being searched are 
generated from the in silico filter program, they are all considered to be modified with at least 
one carbonyl, therefore 50% is the maximum possible coverage for unmodified y and b ions.)  
Fragment ions from the experimental peak lists of un-rejected peptides (percent coverage 
sufficiently high) are compared a second time to the virtual peak list fragment ions; this second 
comparison includes the calculated modification mass.  A peptide is considered a ‘hit’ if a 
minimum of five sequential y or b ions are identified.  For example, y3, y4, y5, y6 and y7 ions 
constitute a hit while y3, y4, y5, y7 and y8 do not.  The user can specify between 0 and 5 
sequential ions to allow for more or less rigor.  This two-fold process (% coverage followed by 
sequential ions) for peptide identification is necessary to limit false positives, since the 
modification mass is unknown.  Once the peptide is identified, the BPI program will back-
calculate the mass of the potential protein carbonyl modification by subtracting the appropriate 
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mass of the ARP biotin tag and output the peptide, the protein and the calculated carbonyl mass.  
A general outline for the BPI program can be seen in Figure 5.   
The BPI program is written to identify carbonyl-modified peptides that are not being 
identified by Mascot.  To test this, the tandem mass spectrometry mgf files generated from the 
ARP-DODE cytochrome c standard were filtered using the in silico filter program (described 
above).  Filter file #3 was searched by the BPI program and Mascot.  To save time, a minimal 
database, containing only cyt c and serum albumin, was used.  The results are shown in Table 2.  
As described above and shown in Table 3A, Mascot successfully identified the three known 
ARP-DODE modified peptides 1GDVEKGK*KIFI10, 98LK*KATNE104 and 
83AGIK*KKTEREDLIAY94.  The BPI program identified these three peptides as well as seven 
other ARP-DODE modified peptides (Table 2B).  These previously unidentified peptides 
consisted of missed cleavages and secondary cleavages for chymotrypsin as well as the peptide 
61K*EETL65, which has also been identified as a minor DODE modification site of cyt c (24).   
To further test the ability of the BPI program to identify the correct carbonyl mass on a 
modified peptide, the peak list for the ARP-DODE modified peptide 1GDVEKGK*KIF10, 
generated from the ARP-DODE cyt c standard (described above), was searched against the entire 
NCBI Equus caballus (horse) database.  The previously described lysine modification was 
known to be ARP-DODE, equivalent to an additional molecular weight of +539 Da.  The input 
parameters for the BPI program were as follows:  digestion enzyme: chymotrypsin; number of 
miss-cleavages: 0; N-acetyl protein modification: yes; background  level: 2; modification mass 
range: 300-800 Da; amino acid/s modified: K, H and C; fragment ions tolerance: ±0.01 Da.  The 
program identified the peptide and correctly calculated the DODE modification of lysine (+ 539 
Da).  The output file generated only two false positive hits (Table 3).  A similar result for the 
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ARP-DODE modified peptide 95LKK*ATNE101, generated from the cyt c standard, is 
summarized in the Supplementary Materials section; Figure 3.  Considering that the peptides 
were searched against the entire NCBI horse database of known proteins and the modification 
mass range was set at ±500 Da these results demonstrate the effectiveness of the evaluation 
criteria in the BPI program.  The Python program code is available to view or for download at: 
http://web.mit.edu/toxms/www/filters.htm. 
Identification of carbonyl modified peptides in SJL mouse serum by database 
search with the BPI program.  To improve the outcome of the BPI program, a searchable 
database was made using the proteins previously identified as carbonyl modified (Supplemental 
Table ST1).  This database served two purposes, first the BPI program is slow and the use of a 
smaller database would enable more searches.  Second, peptides identified by the program from 
this database had a higher likelihood of being a true hit since the proteins were previously 
identified as carbonyl modified.  To identify the carbonyl modification, the mgf files from the 
RcsX infected SJL mouse serum and control mouse serum (described above) were filtered using 
the in silico filter program.  The program conditions used a mass accuracy of ± 0.01 Da and 10% 
maximum peak intensity for fragment ions.  As described above, the presence of three major 
ARP fragment ions in a spectrum was sufficient to select a peptide as modified by the filter 
program, so the filter file #3 generated by the in silico filter was submitted to the BPI program 
for database searching.  The BPI program conditions for database searching were as follows: 
protease: trypsin; missed cleavages: 1; fragment ion mass accuracy: ± 0.01 Da; N-terminus 
acetyl modification: no; variable modification oxidized methionine: yes; percent coverage of un-
modified fragment ions in spectrum: 35%; number of sequential fragment ions required in 
spectrum: 5; low mass range: 329; high mass range: 800; background intensity level: 1.  The low 
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mass range was chosen so that the peptides identified would at least contain a modification 
equivalent to the molecular weight of ARP.  The high mass range of 800 was considered 
sufficient to identify the larger carbonyl modification such as DODE.  The program was run to 
identify the lipid peroxidation carbonyl modifications on amino acids K, H and C; the direct 
side-chain oxidation of residues P, R and K to the semialdehyde carbonyls, and to identify the 
theoretical oxidation of O and N linked glycans at residues S, T and N, and was configured to 
search in silico filtered data with a modification mass range of 300-800 Da.  Since the oxidation 
of P, R and K to form the semialdehydes can reduce the molecular weight of the peptide the low 
mass of 300 was used instead of 331 (mw of ARP).   
The search results on the RcsX infected SJL mouse serum peptides are shown in 4.  The 
MS/MS spectra of all peptide hits were verified manually and these are included in the 
Supplementary Materials section.  As previously seen by Western blot (Figure 1), albumin was 
highly carbonyl-modified.  The DODE-modified peptide 549K*QTALAELVK560, previously 
identified by Mascot, was identified, and the albumin peptide 546QIK*K549 was also identified as 
DODE modified.  The modification of both lysines 548 and 549 was not surprising since runs of 
lysines have previously been seen to be modified by DODE in our in vitro experiments (30).  
Albumin was also modified at peptide 222MK*CSSMQK229; this modification corresponds to 
oxidation  of the lysine 223 side chain to the aminoadipic semialdehyde (scheme 1).  A fourth 
carbonyl modification was found on the albumin peptide 234AFK*AWAVAR242; the calculated 
carbonyl modification mass was + 112 Da and identified on lysine 236.  This carbonyl adduct 
potentially corresponds to the lipid peroxidation product 2-heptenal.  Haptoglobin was modified 
at peptide 112GSFPWQAK*M*ISR123.  The modification of lysine 119 corresponded to direct 
oxidation to the aminoadipic semialdehyde and the modification of methionine 120 as the 
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oxidation product of +16, which had been added as a variable modification during the BPI 
search.  An ONE lipid peroxidation carbonyl modification was identified on lysine 166 of the 
hemopexin peptide 166K*WFWDFATR174.  Carbonyl modifications were also identified on 
hemopexin at peptide 103GPDSVFLIK*EDK114 with the oxidation of lysine 111 to the 
aminoadipic semialdehyde and at peptide 78GHSGTR*ELISAR89 with the oxidation of arginine 
83 to the glutamic semialdehyde.  An HNE lipid peroxidation carbonyl modification was 
identified at hystidine 335 on the inter-alpha trypsin inhibitor, heavy chain 3 peptide 
334DH*LVQATPANLK345.  An HNE modification was found at histidine 431 of the 
muranoglobulin-1 peptide 431H*ASAK435.  A second HNE carbonyl modification was identified 
at histidine 856 on the muranoglobulin-1 or muranoglobulin-2 peptide 856H*TSSWLVTPK865.  
Pregnancy zone protein (or alpha-2-macroglobulin precursor) was seen to be modified by the 
oxidation of lysine 306 to the aminoadipic semialdehyde on peptide 305TK*VFQLR311 and with a 
possible 2-heptinal modification at lysine 1205 on peptide 1204VK*ALSFYQPR1213.  Transferrin 
was modified by the oxidation of proline 164 to the glutamic semialdehyde carbonyl on the 
peptide 163SP*LEK167; by the oxidation of lysine 299 to the aminoadipic semialdehyde on the 
peptide 298SK*DFQLFSSPLGK310; by the modification of hystidine 268 with the lipid 
peroxidation adduct HNE on the peptide 265IPSH*AVVAR273; and by the oxidation of either 
lysine 274 or 278 to the aminoadipic semialdehyde carbonyl on the peptide 
274K?NNGK?EDLIWEILK287 (the exact modification site could not be determined).   
 As shown in Table 4, carbonyl modified peptides were found on a number of proteins 
from the database, including alpha-2-HS-glycoprotein, alpha-2-macroglobulin apolipoprotein 
A1, apolipoprotein E, ceruloplasmin isoform a and b, compliment component 3, esterase 1 and 
serine (or cysteine) proteinase inhibitor, although the specifically modified peptides could not be 
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identified.  The inability to identify a carbonyl modification on Apo A1 was surprising 
considering that its modification by HNE has been reported (32).   
 
Discussion 
Carbonyl modified proteins have proven difficult to analyze, and only a few studies have 
correctly identified the peptides from endogenously-modified proteins.  In this study a number of 
protein carbonyls were identified in serum of the SJL mouse inflammation model.  Modified 
proteins and peptides were identified using biotin/avidin affinity in conjunction with new 
software developed in-house that filtered and searched spectra that were not identified during 
Mascot database searching. 
Mascot is a powerful tool for database searching, quantification and identification of 
protein modifications.  Large modifications, however, can fragment during MS/MS CID and 
these can interfere with Mascot searches (23,33).  Regardless of spectral quality, the ARP-biotin 
modified peptides will generate Mascot scores that are lower than those for the corresponding 
unmodified peptides.  To identify modified peptides the researcher must therefore lower the 
statistical cut-off point at which spectra are accepted or rejected, consequently leading to an 
increase in the number of false positives.  Furthermore, the low score requires that all identified 
peptides be manually or visually verified.  Even relatively simple systems (such as the ARP-
DODE-modified cytochrome c standard used here) become increasingly difficult to analyze and 
result in many low-scoring identifications, the majority of which are artifacts.  For an in vivo 
sample, these problems are compounded by the complexity of the sample and the sample 
processing, resulting in an inevitable increase in the generation of false positives.   
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Two programs were written to help overcome some of the problems associated with 
database searching and identifying biotinylated carbonyl-modified proteins in the SJL mouse 
serum.  The in silico filter program takes advantage of the biotin-ARP modification-specific ions 
that are formed during peptide fragmentation.  The same ions that impede effective peptide 
identification can be used as a fingerprint to highlight modified peptides in the mass 
spectrometry data.  Using this program, modified peptides are filtered in silico from the mass 
spectrometry data, resulting in a new data file containing only carbonyl modified peptides.  
Mascot database searching of the filtered files result in a reduced the number of false positives, 
simplifying manual verification of modified peptides.    
To improve the identification of the in silico filtered peptides, other types of evaluation 
criteria were explored using an in-house database search algorithm (biotin peptide identification 
program, BPI) that evaluates the theoretical number of unmodified peptide fragments (y and b 
ions) and the number of sequentially identified modified and unmodified peptide y and b ion 
fragments (the longer the sequence the lower the probability of a mismatch).  The peptides are 
searched in this de novo-like fragment-dependent manner resulting in modified peptide 
identification without the necessity of knowing the carbonyl modification mass.  The calculated 
modification mass is part of the BPI software output along with the peptide/protein 
identification.  The program identifies ARP-carbonyl modified peptide standards from a 
mammalian database, and calculates the correct modification mass with a minimal number of 
false identifications.   
The BPI program was written as a specialized database search engine for identifying 
biotin-derivatized peptides from data generated by the in silico filter program.  It was also 
designed to use a simplified database of known modified proteins.  It therefore does not calculate 
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probability scores for peptides since output is kept to a minimum and can easily be manually 
verified.  Without probability scores, the program does not bias searches with scoring criteria and 
is able to identify modified peptides not seen during Mascot searching.  Although the program 
allows complete access to the data analysis portion of this research, it is relatively inflexible with 
respect to its use as a general database search engine, since such searching requires good 
statistical peptide scoring as well as an ability to search large quantities of data in a relatively 
short time. 
It should be stated that both the in silico filter and BPI programs were written to be a 
semi-empirical approach to identifying spectra from modified peptides. The programs identify 
spectra that correspond to a few modified peptides, making manual verification possible.  These 
programs use no statistical calculations to limit the number of false positives and manual 
verification is required. The BPI and the in silico filter were written to help with the 
identification of peptides with large biotinylated modifications and are therefore somewhat 
specialized.  A referee noted that comparisons of the approach with different instrument types, 
e.g., ion-traps (typically richer in b-ions) vs quadrupole time-of-flight, could expand the range 
and usefulness of the software for identification of other large peptide modifications.  Both 
program codes are available at http://web.mit.edu/toxms/www/filters.htm.    
The primary goal of this study was to identify carbonyl protein modifications in serum 
from the SJL mouse.  A number of modifications, including HNE, ONE, DODE and a potential 
2-heptenal modification, were identified from the lipid peroxidation pathway.  HNE modification 
of histidine was identified on three proteins (Table 4), while DODE and ONE modifications 
were identified only on albumin and hemopexin respectively.  This result is somewhat contrary 
to our previous studies in which DODE was the most reactive aldehyde formed from the 
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hydroperoxide of linoleic acid (30). A more-abundant HNE modification in vivo, however, may 
not be not surprising since a lower reactivity would give the HNE aldehyde a longer half-life, 
allowing more opportunities for protein modification. 
Carbonylation also arose through the direct oxidation of amino acid side chains of 
proline, lysine or arginine, and the formation of the aminoadipic and glutamic semialdehydes.   
These modifications were identified on albumin, haptoglobin, pregnancy zone protein and 
transferrin, and have often been considered a major source of protein carbonyls occurring from 
the production of free radicals by copper or iron Fenton chemistry.  Transferrin and hemopexin 
were highly modified with semialdehyde carbonyls, with hemopexin containing the only 
oxidized arginine identified in the study.  This is an interesting result considering that the 
biological function of these proteins involves the sequestering and transport of iron, likely 
making them more susceptible to Fenton chemistry.   
As shown in Table 4, the modified peptides for a number of candidates for protein 
carbonyl modification remained unidentified.  These were marked as “potential DODE” 
modifications if the protein was identified from an anti-DODE western gel or as “unknown 
carbonyl” if the protein was identified after biotin/avidin enrichment. The identities and potential 
carbonyl modification of these proteins will be addressed in future experiments. 
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Legends. 
 
Scheme 1.  Direct oxidative carbonylation of proteins to form glutamate and aminoadipate 
semialdehydes. 
 
Scheme 2.  Reactive aldehydes, arising from oxidation of polyunsaturated fatty acids and 
carbohydrates, can indirectly lead to protein carbonylation 
 
Figure 1.  Western blot analysis of ARP-derivatized and non-derivatized serum proteins from 
control and infected SJL mice. 
 
Figure 2:  MS/MS of unmodified (A) and DODE-ARP-modified (B) peptide.  (C) Major CID 
fragments of the ARP tag.   
 
Figure 3:  Collision induced dissociation analysis of the unmodified (red) and modified (black) 
peptide, acyl-GDVEKGK*KIF.  (A) Mascot peptide score with increasing collision energy.  (B) 
Fragmentation efficiency (defined as the ratio of the summed abundances of identified product 
ions divided by the total ion abundance). 
 
Figure 4: ARP-DODE modified peptide (K*QTALAELVK) identified on mouse serum albumin.  
(A) From infected mouse serum.  (B)  From mouse serum albumin treated in vitro with DODE. 
 
Figure 5: Software workflow for the identification of biotin derivatized protein carbonyls. 
 
Table 1: Mascot search results on DODE-ARP modified BSA and cyt c  standards with and 
without the in silico filter. A: Pre-filter; multiple peptides are identified both modified and 
unmodified.  B: Post filter; all un-modified peptides are eliminated and only modified peptides 
are identified along with the elimination of one false positive. 
 
Table 2: Search results on DODE-ARP modified cyt C and BSA, after in silico filtration.  A: 
Mascot search results.  B: BPI search results.  BPI is able to identify a number of low abundant 
modified peptides that remain un-scored by Mascot.  Many of these peptides are secondary 
cleavage sites of chymotrypsin.   
 
Table 3: Output file from BPI program after searching the ARP-DODE modified peptide 
GDVEKGK*KIF against the entire NCBI Equus caballus database.  The modification and 
cytochrome c were correctly identified along with two false positives.  
 
Table 4: Carbonyl modified proteins in SJL mouse serum. 
 







Table 1.  Search results on DODE-ARP-modified BSA and cytochrome c standards with 
and without the in silico  filter. 
A. Mascot results pre-filter B. Mascot results post-filter
CTRA_BOVIN    Mass: 25650    Score: 95
Observed   Peptide
412.7117  L.KLSTAASF.S
412.7117  L.KLSTAASF.S
437.7442  W.TLVGIVSW.G
494.25  L.VNWVQQTL.A
508.7666  L.TINNDITLL.K
515.2791  Y.ARVTALVNW.V
561.7727  W.QVSLQDKTGF.H
561.7727  W.QVSLQDKTGF.H
562  W.QVSLQDKTGF.H
665.8442  Y.NSLTINNDITLL.K
580.2862  Y.TNANTPDRLQQASLPL.L
836  L.SNTNCKK...V + ARP-DODE
K1C19_BOVIN    Mass: 43858    Score: 88     
Observed  Peptide
629.3182  L.QGLEIELQSQL.S
644.8137  L.ATSDGLLAGNEKL.T
CYC_HORSE    Mass: 11825    Score: 58 CYC_HORSE    Mass: 11825    Score: 0
Observed   Peptide Observed   Peptide
453.7245  Y.IPGTKMIF.A
453.7435  Y.IPGTKMIF.A
521.7312  W.KEETLMEY.L
578.2595  W.KEETLMEYL.E
388.2056  M.GDVEKGKKIF.V + Acetyl (N-term)
416.5401  Y.TDANKNKGITW.K
671.8357  Y.LKKATNE.- + ARP-DODE 671.8357  Y.LKKATNE.- + ARP-DODE 
791.337  W.KEETLMEY.L + ARP-DODE 791.337  W.KEETLMEY.L + ARP-DODE
567.9459  M.GDVEKGKKIF.V + ARP-DODE 567.9459  M.GDVEKGKKIF.V + ARP-DODE 
434.4877  F.AGIKKKTEREDLIAY.L
596.2787  Y.TDANKNKGITW.K + ARP-DODE 596.2787  Y.TDANKNKGITW.K + ARP-DODE 
607.9433  F.GRKTGQAPGFTY.T + ARP-DODE 607.9433  F.GRKTGQAPGFTY.T + ARP-DODE
K2CA_BOVIN    Mass: 18124    Score: 24
Observed Peptide
302.6675  L.MNVKL.A
504.7448  L.ALDIEIATY.R
GFAP_BOVIN    Mass: 49422   Score: 24
Observed Peptide
380.1978 L.AAELNQL.R
504.7488 L.ALDIEIATY.R
Table 2: Search results on DODE-ARP modified cyt C and BSA, after in silico  filtration. 
 A: Mascot search results.  B: BPI search results
A: Mascot
CYC HORSE Mass: 11825 CYC HORSE Mass: 11825
Observed Peptide Observed Peptide
551.3053 F.AGIKKKTEREDLIAY.L + ARP-ONE 551.3053 F.AGIKKKTEREDLIAY.L + ARP-ONE
567.9582 M.GDVEKGKKIF.V + Acetyl: ARP-DODE 567.9582 M.GDVEKGKKIF.V + Acetyl: ARP-DODE
615.2261 KKATNE + ARP-DODE
635.8450 Y.LKKATNE.- +ARP-ONE
659.2501 E NPKKY +ARP-DODE
671.8545 Y.LKKATNE.- +ARP-DODE 671.8545 Y.LKKATNE.- +ARP-DODE
579.7067 KEETL +ARP-DODE
642.9370 AGIKKKTE RE DL + ARP-DODE
482.4455 AGIKKKTEREDL + ARP-DODE
715.7666 LENPKKY +ARP-DODE
758.7309 F.AGIKKKTEREDLIAY.L + ARP-DODE 758.7309 F.AGIKKKTEREDLIAY.L + ARP-DODE
 
B: Biotin-peptide ID algorithm (BPI)
Table 3.  Output file from the BPI program after searching the ARP-DODE-modified peptide
GDVEKGK*KIF against the NCBInr Equus caballus  database.
Correctly identified modified peptide Two false positives
GDVEKGkKIF kSALMPAQLF 
XP_001498872.1 PREDICTED: similar to XP_001497818.1 PREDICTED: similar to 
Cytochrome c [Equus caballus] Phosphoinositide-3-kinase, class 3 [Equus caballus]
Mass spec monoisotopic mass: 567.9229 Mass spec monoisotopic mass: 567.9229 
Charge: + 3 Elution: 52.22 to 53.3 min Charge: + 3 Elution: 52.22 to 53.3 min
Biotin modification mass: 539.1057 Biotin modification mass: 596.14450 
Carbonyl modificaton mass: 226.2327 Carbonyl modificaton mass: 283.2719 
y ions y ions
(1, '+', 166.0950) (1, '+', 166.0950)
(2, '+', 279.1613) (2, '+', 279.1613)
(3, '+', 407.2481) (3, '+', 407.2481)
(4, '+', 1074.4848) (4, '+', 478.2573)
(6, '++', 630.3097) (5, '+', 575.3043)
(7, '++', 694.8194) (6, '+', 706.3402
(7, '-331 neut. loss ++', 529.2677) (7, '++', 410.2204)
(8, '++', 744.3611) (8, '+', 890.4671)
(8, '-331 neut. loss ++', 578.8039) (8, '++', 445.7426)
(9, '++', 801.8539) (9, '++', 489.2415)
(10, '-331 neut. loss ++', 685.8180) (10, '-331 neut. loss ++', 685.8180)
b ions b ions
(1, '+', 100.05802) (7, '-331 neut. loss +', 964.4102)
(2, '+', 215.0707)
(3, '+', 314.1196) VkAELAISTF 
(4, '+', 443.1598) XP_001500348.1 PREDICTED: similar to protein 
(5, '+', 571.2721) tyrosine phosphatase, receptor type, T [Equus caballus]
(5, '++', 286.1342) Mass spec monoisotopic mass: 567.9229
Charge: + 3 Elution: 52.22 to 53.3 min
Biotin modification mass: 623.1381
Carbonyl modificaton mass: 310.2650
y ions
(1, '+', 166.0950)
(2, '+', 267.1457)
(4, '+', 467.2438)
(5, '+', 538.2739)
(6, '+', 651.3539)
(7, '+', 780.4013)
(8, '+', 851.4590)
(8, '++', 426.2275)
(9, '++', 801.8539)
(10, '-331 neut. loss ++', 685.8180)
b ions
(1, '+', 100.05802)
(9, '++', 801.8539)
(10, '-331 neut. loss ++', 685.8180)
Experimental/Calculated Modification Mass
Protein Name Accession Number Modified Peptide Modification Precursor (m/z ) ARP + Carbonyl Carbonyl
Albumin NP_033784 K*QTALAELVK DODE 547.2894 (+3) 539.1868 226.2337
QIK*K DODE 528.2976 (+2) 539.2443 226.3712
MK*CSSMQK aminoadipic semialdehyde 627.7645 (+2) 312.0997 -0.7734
AFK*AWAVAR 2-heptenal 482.2532 (+3) 425.1982 112.3252
Alpha-2-HS-glycoprotein* NP_038493 ? possible DODE 
Alpha-2-macroglobulin* NP_783327.1 possible DODE
Apolipoprotein A1* NP_659146 possible DODE
Apolipoprotein E* NP_033826.1 possible DODE
Ceruloplasmin isoform a and b** NP_001036076 ?  unknown carbonyl
NP_031778 
Compliment Component 3 NP_033908 ? unknown carbonyl
Esterase 1 NP_031980 ? unknown carbonyl
Haptoglobin NP_059066 GSFPWQAK*M*ISR aminoadipic semialdehyde 579.2786 (+3) 312.1156 -0.7575
Hemopexin NP_059067 K*WFWDFATR ONE 575.2934 (+3) 467.2580 154.3850
GPDSVFLIK*EDK aminoadipic semialdehyde 553.948 (+3) 312.1233 -0.7497
GHSGTR*ELISAR glutamic semialdehyde 518.5875 (+3) 270.0801 -42.7930
Inter-alpha trypsin inhibitor, heavy chain 3 NP_032433 DH*LVQATPANLK HNE 592.6391 (+3) 469.1960 156.3230
Kininogen 2 NP_958763 ? unknown carbonyl
Murinoglobulin 1 NP_032671 H*ASAK HNE 491.7722 (+2) 469.2623 156.3893
Murinoglobulin 1 or 2 NP_032672 H*TSSWLVTPK HNE 542.2829 (+3) 469.2149 156.3418
Pregnancy zone protein NP_031402 VK*ALSFYQPR 2-heptenal 545.2964 (+3) 425.2054 112.3323
TK*VFQLR aminoadipic semialdehyde 602.3050 (+2) 312.0764 -0.7966
Serine (or cysteine) proteinase inhibitor** NP_955018 ? unknown carbonyl
NP_659083 
NP_082273 
XP_282560 
NP_035588 
Transferrin NP_598738 SP*LEK glutamic semialdehyde 451.7331 (+2) 329.1437 16.2706
KNNGK*EDLIWEILK aminoadipic semialdehyde 671.3462 (+3) 312.0999 -0.7731
K*NNGKEDLIWEILK aminoadipic semialdehyde 671.3462 (+3) 312.0999 -0.7731
SK*DFQLFSSPLGK aminoadipic semialdehyde 589.3111 (+3) 312.1466 -0.7265
IPSH*AVVAR HNE 473.6003 (+3) 469.2462 156.3731
* Protein identified as DODE modified by 2-D SDS PAGE and anti-DODE western
**Protein identified as carbonyl modified after biotin affinity chromatography
